View Older Stories

May 1, 2026 07:30AM Arrowhead receives Australia approval for rare disease drug REDEMPLO

May 1, 2026 01:56AM JPMorgan Starts Arrowhead Pharma (ARWR) at Overweight

Apr 21, 2026 03:34AM Morgan Stanley Upgrades Arrowhead Pharma (ARWR) to Overweight

Mar 30, 2026 04:21AM Arrowhead presents long-term plozasiran data for hypertriglyceridemia

Mar 26, 2026 02:33PM TD Cowen on Arrowhead Pharma (ARWR): 'We remain at Buy as the pipeline remains robust'

Mar 26, 2026 11:12AM Arrowhead Pharma (ARWR) PT Lowered to $81 at BofA Securities

Mar 25, 2026 03:05PM Leerink Partners on Arrowhead Pharma (ARWR): SRPT data drives shares up despite IONS pricing update

Mar 18, 2026 09:21AM RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'

Feb 9, 2026 09:46AM Goldman Sachs Reiterates Neutral Rating on Arrowhead Pharma (ARWR)

Feb 5, 2026 04:11PM Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q1 EPS by 10c

Feb 4, 2026 05:18PM Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600

Jan 27, 2026 09:58AM Morgan Stanley on Arrowhead Pharma (ARWR): 'we are encouraged by the on track progress for the ARO-DIMER-PA program'

Jan 22, 2026 06:40AM Arrowhead Pharma (ARWR) PT Raised to $100 at H.C. Wainwright

Jan 16, 2026 07:07AM Arrowhead Pharma (ARWR) Reiterated at Overweight by Cantor Fitzgerald

Jan 13, 2026 09:07AM 'Arrowhead Pharma (ARWR) Raises $930 Million to Launch Redemplo'; PT Raised at Piper Sandler

Jan 12, 2026 05:05PM Arrowhead Pharmaceuticals raises $700 million in convertible notes

Jan 7, 2026 08:36AM Bernstein on Arrowhead Pharma (ARWR): 'Obesity Data Meets Our Solid Win Scenario'

Jan 7, 2026 07:45AM Arrowhead Pharma (ARWR) Reiterated at Overweight by Cantor Fitzgerald

Jan 7, 2026 07:32AM Arrowhead receives China approval for rare disease drug REDEMPLO

Jan 7, 2026 04:16AM Arrowhead Pharma (ARWR) PT Raised to $84 at BofA Securities

Jan 7, 2026 03:58AM Goldman Sachs Reiterates Neutral Rating on Arrowhead Pharma (ARWR)

Jan 6, 2026 07:30AM Arrowhead Pharmaceuticals reports interim obesity drug trial results

Jan 5, 2026 07:30AM Health Canada approves Arrowhead's REDEMPLO for rare triglyceride disorder

Jan 2, 2026 08:22AM Arrowhead Pharma (ARWR) PT Raised at Bernstein Ahead of Obesity Data Update

Dec 23, 2025 05:30PM Jefferies lists 5 biotech M&A candidates for 2026

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 21, 2025 04:00AM Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026

Dec 19, 2025 09:06AM TD Cowen on Biotechnology: '10+ Potential "Thome Run" Catalysts To Watch In 2026'

Dec 17, 2025 06:56AM Piper Sandler Names Arrowhead Pharma (ARWR) 'A Top Pick for 2026', Lifts Stock PT

Dec 11, 2025 06:06AM Arrowhead Pharmaceuticals Inc. (ARWR) files mixed shelf

Dec 11, 2025 05:59AM Arrowhead Pharma (ARWR) PT Raised to $80 at RBC Capital

Dec 3, 2025 06:42AM Arrowhead Pharma (ARWR) PT Raised to $85 at H.C. Wainwright

Dec 1, 2025 06:26AM Arrowhead Pharma (ARWR) PT Raised to $62 at BofA Securities

Nov 24, 2025 07:30AM Arrowhead Pharmaceuticals receives $200 million from Sarepta milestone

Nov 19, 2025 09:14AM TD Cowen on Arrowhead Pharma (ARWR): 'Momentum Is Strong; Buy'

Nov 19, 2025 09:06AM Arrowhead Pharma (ARWR) PT Raised at RBC Capital Following Redemplo Approval

Nov 19, 2025 08:51AM Arrowhead Pharma (ARWR) PT Raised at Piper Sandler Following FDA Approval

Nov 19, 2025 07:28AM Arrowhead Pharma's (ARWR) Redemplo Approved in FCS - Cantor Fitzgerald

Nov 19, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on Arrowhead Pharma (ARWR)

Nov 18, 2025 12:15PM Arrowhead Pharmaceuticals Inc. (ARWR) resumes trading

Nov 18, 2025 11:17AM FDA approves Arrowhead's Redemplo to reduce triglycerides in adults with familial chylomicronemia syndrome

Nov 18, 2025 11:14AM Arrowhead Pharmaceuticals Inc. (ARWR) halted, news pending

Nov 11, 2025 04:23PM Arrowhead Pharma (ARWR) PT Raised to $45 at Morgan Stanley

Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'

Oct 8, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Arrowhead Pharma (ARWR)

Oct 7, 2025 07:31AM Arrowhead files application for dual-gene RNAi therapy trial

Sep 11, 2025 07:30AM Arrowhead files lawsuit against Ionis over plozasiran patent dispute

Sep 3, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Arrowhead Pharma (ARWR)

Sep 2, 2025 07:30AM Arrowhead Pharmaceuticals partners with Novartis for $200 million deal

Aug 13, 2025 04:10PM Arrowhead receives $100 million milestone from Sarepta in mixed payment

View Older Stories